Cornerstone Management’s Bristol-Myers Squibb BMY Stock Holding History

Cornerstone Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,791	Closed	-$124K	–	72
2023 Q1	$124K	Hold	1,791	–	–	0.03%	60
2022 Q4	$129K	Sell	1,791 -150	-8%	-$11.3K	0.04%	56
2022 Q3	$138K	Hold	1,941	–	–	0.04%	54
2022 Q2	$149K	Hold	1,941	–	–	0.04%	57
2022 Q1	$142K	Hold	1,941	–	–	0.03%	60
2021 Q4	$121K	Buy	+1,941	New	+$114K	0.03%	62
2017 Q3	–	Sell	-6,733	Closed	-$375K	–	32
2017 Q2	$375K	Sell	6,733 -1,023	-13%	-$55.7K	0.2%	27
2017 Q1	$422K	Sell	7,756 -50	-0.6%	-$2.74K	0.22%	25
2016 Q4	$456K	Hold	7,806	–	–	0.26%	26
2016 Q3	$421K	Hold	7,806	–	–	0.25%	30
2016 Q2	$574K	Hold	7,806	–	–	0.35%	26
2016 Q1	$499K	Hold	7,806	–	–	0.31%	26
2015 Q4	$537K	Hold	7,806	–	–	0.35%	26
2015 Q3	$462K	Buy	7,806 +400	+5%	+$25.4K	0.35%	27
2015 Q2	$493K	Sell	7,406 -200	-3%	-$13.2K	0.35%	26
2015 Q1	$491K	Hold	7,606	–	–	0.37%	27
2014 Q4	$449K	Buy	+7,606	New	+$429K	0.35%	28

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cornerstone Management's BMY Position: Q2 2023 in Review

Cornerstone Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 1,791 shares — an estimated $124K sold.

Cornerstone Management first reported a position in BMY in Q4 2014 and held it in 17 quarters. The position peaked at $574K in Q2 2016. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Cornerstone Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Cornerstone Management sold 1,791 Bristol-Myers Squibb shares in Q2 2023, an estimated $124K.
Cornerstone Management first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 17 quarters.
Cornerstone Management's Bristol-Myers Squibb position peaked at $574K in Q2 2016.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Cornerstone Management's 13F filing for Q2 2023, filed 10 Aug 2023.